ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GENE Genetic Technologies Ltd

2.71
0.02 (0.74%)
Mar 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 26,828
Bid Price 2.73
Ask Price 2.95
News -
Company Name Stock Ticker Symbol Market Type
Genetic Technologies Ltd GENE NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.02 0.74% 2.71 18:48:23
Open Price Low Price High Price Close Price Prev Close
2.65 2.61 2.7846 2.71 2.69
Trades Volume VWAP Dollar Volume Avg Volume
196 26,828  2.73  73,288 -
Last Trade Time Type Quantity Stock Price Currency
16:28:14 20  2.65 USD

Genetic Technologies Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.32B 10.96B - 10.35M -11.75M -0.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Genetic Technologies

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No GENE Message Board. Create One! See More Posts on GENE Message Board See More Message Board Posts

GENE Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States.

Your Recent History

Delayed Upgrade Clock